IL145582A0 - Monthly doses for treatment of streptococcus pneumoniae infections - Google Patents

Monthly doses for treatment of streptococcus pneumoniae infections

Info

Publication number
IL145582A0
IL145582A0 IL14558200A IL14558200A IL145582A0 IL 145582 A0 IL145582 A0 IL 145582A0 IL 14558200 A IL14558200 A IL 14558200A IL 14558200 A IL14558200 A IL 14558200A IL 145582 A0 IL145582 A0 IL 145582A0
Authority
IL
Israel
Prior art keywords
treatment
streptococcus pneumoniae
pneumoniae infections
monthly doses
monthly
Prior art date
Application number
IL14558200A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL145582A0 publication Critical patent/IL145582A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL14558200A 1999-05-03 2000-04-19 Monthly doses for treatment of streptococcus pneumoniae infections IL145582A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (fr) 1999-05-03 2000-04-19 DOSES MENSUELLES DESTINEES AU TRAITEMENT DES INFECTIONS PAR $i(STREPTOCOCCUS PNEUMONIAE)

Publications (1)

Publication Number Publication Date
IL145582A0 true IL145582A0 (en) 2002-06-30

Family

ID=22453188

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14558200A IL145582A0 (en) 1999-05-03 2000-04-19 Monthly doses for treatment of streptococcus pneumoniae infections
IL145582A IL145582A (en) 1999-05-03 2001-09-24 Use of NDISACC (4- (4-chlorophenyl) -benzyl) B82846A or tycoplanin, in the preparation of long-term treatment drugs for the prevention of streptococcal pneumoniae infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145582A IL145582A (en) 1999-05-03 2001-09-24 Use of NDISACC (4- (4-chlorophenyl) -benzyl) B82846A or tycoplanin, in the preparation of long-term treatment drugs for the prevention of streptococcal pneumoniae infections

Country Status (29)

Country Link
EP (1) EP1175222B1 (fr)
JP (1) JP2002543146A (fr)
KR (1) KR100757165B1 (fr)
CN (1) CN1349407A (fr)
AR (1) AR023827A1 (fr)
AT (1) ATE284702T1 (fr)
AU (1) AU774647B2 (fr)
BR (1) BR0010244A (fr)
CA (1) CA2372790A1 (fr)
CZ (1) CZ296127B6 (fr)
DE (1) DE60016734T2 (fr)
DZ (1) DZ3039A1 (fr)
EA (1) EA004295B1 (fr)
HK (1) HK1044707B (fr)
HR (1) HRP20010808A2 (fr)
HU (1) HUP0200940A3 (fr)
IL (2) IL145582A0 (fr)
MY (1) MY123542A (fr)
NO (1) NO20015291L (fr)
NZ (1) NZ514467A (fr)
PE (1) PE20010292A1 (fr)
PL (1) PL353444A1 (fr)
SK (1) SK285970B6 (fr)
SV (1) SV2002000065A (fr)
TR (1) TR200103211T2 (fr)
TW (1) TWI255716B (fr)
UA (1) UA73937C2 (fr)
WO (1) WO2000066144A2 (fr)
ZA (1) ZA200108013B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2297830C1 (ru) * 2005-09-27 2007-04-27 Леонид Федосеевич Ляпустин Способ лечения воспалительных заболеваний легких
PT3006038T (pt) * 2008-08-30 2024-08-23 The Medicines Co Doses únicas de oritavancina para tratamento ou prevenção de uma infeção bacteriana
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
LT3038616T (lt) * 2013-08-26 2023-05-25 Melinta Therapeutics, Inc. Bakteriemijos ir osteomielito gydymo būdai naudojant oritavanciną

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
EP1175222A2 (fr) 2002-01-30
WO2000066144A2 (fr) 2000-11-09
DZ3039A1 (fr) 2004-03-27
CZ296127B6 (cs) 2006-01-11
TR200103211T2 (tr) 2002-02-21
HK1044707B (en) 2005-09-30
MY123542A (en) 2006-05-31
CN1349407A (zh) 2002-05-15
HUP0200940A3 (en) 2002-10-28
EA200101171A1 (ru) 2002-04-25
ZA200108013B (en) 2003-03-26
TWI255716B (en) 2006-06-01
SK285970B6 (sk) 2007-12-06
SK15572001A3 (sk) 2003-05-02
PE20010292A1 (es) 2001-03-07
UA73937C2 (en) 2005-10-17
CA2372790A1 (fr) 2000-11-09
KR100757165B1 (ko) 2007-09-07
SV2002000065A (es) 2002-12-02
AU774647B2 (en) 2004-07-01
HUP0200940A2 (en) 2002-08-28
AU4329200A (en) 2000-11-17
JP2002543146A (ja) 2002-12-17
ATE284702T1 (de) 2005-01-15
IL145582A (en) 2008-12-29
NO20015291L (no) 2001-12-17
DE60016734T2 (de) 2005-12-08
BR0010244A (pt) 2002-01-08
AR023827A1 (es) 2002-09-04
EP1175222B1 (fr) 2004-12-15
WO2000066144A3 (fr) 2001-04-12
NZ514467A (en) 2005-01-28
PL353444A1 (en) 2003-11-17
KR20020008173A (ko) 2002-01-29
HRP20010808A2 (en) 2002-12-31
EA004295B1 (ru) 2004-02-26
DE60016734D1 (de) 2005-01-20
CZ20013949A3 (cs) 2002-07-17
HK1044707A1 (en) 2002-11-01
NO20015291D0 (no) 2001-10-29

Similar Documents

Publication Publication Date Title
IL148641A0 (en) Topical treatment of streptococcal infections
SI1162999T1 (sl) Vakcina proti Streptococcus pneumoniae
EP1162994A4 (fr) Composition pour le traitement prophylactique et therapeutique des infections a streptocoques
HUP0301815A3 (en) Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment
AU4832000A (en) Methods for quantitating the efficacy of oral care products
HUP0201206A2 (en) Antibacterial compounds, process for their preparation and pharmaceutical compositions containing them
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
GB9918760D0 (en) Topical treatment
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL145582A0 (en) Monthly doses for treatment of streptococcus pneumoniae infections
IL133760A0 (en) Composition for the treatment of dandruff
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
AU4145999A (en) Topical drug for the treatment of viral infections
GB9419571D0 (en) Treatment of oral infections
AU2002336752A1 (en) Composition for treating streptococcus pneumoniae
GB9928678D0 (en) Streptococcus pneumoniae antigens
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
NO991827D0 (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon
GB9904252D0 (en) Composition for the treatment of pain
AU1673200A (en) Medicaments for the treatment of lung infections
GB0117819D0 (en) Pharmaceutical preparation for treating viral infections
HK1047543A (en) Topical treatment of streptococcal infections